US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.1371
  • -0.0129-1.12%
Close Nov 22 16:00 ET
  • 1.1371
  • 0.00000.00%
Post 20:01 ET
2.32MMarket Cap-85P/E (TTM)

Dermata Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-Cash and cash equivalents
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
Receivables
----
----
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
-Accrued interest receivable
----
----
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
Prepaid assets
-23.55%506.56K
-47.80%111.16K
-21.13%347.92K
-23.76%517.65K
-23.76%517.65K
-22.85%662.58K
-37.94%212.93K
-25.79%441.12K
-11.75%678.99K
-11.75%678.99K
Current deferred assets
----
--116.76K
----
----
----
----
----
----
----
----
Other current assets
26.60%37.03K
1.50%61.54K
21.38%98.16K
24.94%14.5K
24.94%14.5K
-19.67%29.25K
9.36%60.63K
2.28%80.87K
--11.6K
--11.6K
Total current assets
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-8.69%6.69M
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
Liabilities
Current liabilities
Payables
82.02%863.6K
203.16%1.33M
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-accounts payable
82.02%863.6K
203.16%1.33M
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
Current accrued expenses
566.57%755.29K
396.35%313.28K
-45.38%318.41K
-83.92%41.1K
-83.92%41.1K
-82.51%113.31K
-86.28%63.12K
83.09%582.91K
8.56%255.54K
8.56%255.54K
Current liabilities
112.27%1.95M
180.94%1.92M
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
112.27%1.95M
180.94%1.92M
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
Shareholders'equity
Share capital
-47.34%168
-78.37%69
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
-common stock
-47.34%168
-78.37%69
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
Retained earnings
-21.99%-62.52M
-19.82%-59.35M
-18.16%-56.52M
-17.10%-53.39M
-17.10%-53.39M
-16.69%-51.25M
-19.36%-49.53M
-23.38%-47.83M
-26.71%-45.59M
-26.71%-45.59M
Paid-in capital
16.66%67.27M
8.87%62.67M
7.88%60.33M
15.75%59.74M
15.75%59.74M
12.19%57.66M
12.52%57.56M
19.95%55.92M
11.99%51.61M
11.99%51.61M
Total stockholders'equity
-25.99%4.74M
-58.68%3.32M
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
Total equity
-25.99%4.74M
-58.68%3.32M
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -7.35%6.14M-41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M
-Cash and cash equivalents -7.35%6.14M-41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M
Receivables -------------33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K
-Accrued interest receivable -------------33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K
Prepaid assets -23.55%506.56K-47.80%111.16K-21.13%347.92K-23.76%517.65K-23.76%517.65K-22.85%662.58K-37.94%212.93K-25.79%441.12K-11.75%678.99K-11.75%678.99K
Current deferred assets ------116.76K--------------------------------
Other current assets 26.60%37.03K1.50%61.54K21.38%98.16K24.94%14.5K24.94%14.5K-19.67%29.25K9.36%60.63K2.28%80.87K--11.6K--11.6K
Total current assets -8.69%6.69M-39.90%5.24M-44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -8.69%6.69M-39.90%5.24M-44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M
Liabilities
Current liabilities
Payables 82.02%863.6K203.16%1.33M66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K
-accounts payable 82.02%863.6K203.16%1.33M66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K
Current accrued expenses 566.57%755.29K396.35%313.28K-45.38%318.41K-83.92%41.1K-83.92%41.1K-82.51%113.31K-86.28%63.12K83.09%582.91K8.56%255.54K8.56%255.54K
Current liabilities 112.27%1.95M180.94%1.92M13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 112.27%1.95M180.94%1.92M13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K
Shareholders'equity
Share capital -47.34%168-78.37%69178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%77
-common stock -47.34%168-78.37%69178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%77
Retained earnings -21.99%-62.52M-19.82%-59.35M-18.16%-56.52M-17.10%-53.39M-17.10%-53.39M-16.69%-51.25M-19.36%-49.53M-23.38%-47.83M-26.71%-45.59M-26.71%-45.59M
Paid-in capital 16.66%67.27M8.87%62.67M7.88%60.33M15.75%59.74M15.75%59.74M12.19%57.66M12.52%57.56M19.95%55.92M11.99%51.61M11.99%51.61M
Total stockholders'equity -25.99%4.74M-58.68%3.32M-52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M
Total equity -25.99%4.74M-58.68%3.32M-52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data